The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers

NCT00820703 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped For business reasons

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Nexagon®
DRUG: Nexagon® vehicle

Sponsor

OcuNexus Therapeutics, Inc.